Literature DB >> 27157539

'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road.

Monica J Barratt1, Simon Lenton2, Alexia Maddox2, Matthew Allen3.   

Abstract

BACKGROUND: Cryptomarkets are digital platforms that use anonymising software (e.g. Tor) and cryptocurrencies (e.g. Bitcoin) to facilitate peer-to-peer (P2P) trade of goods and services. Their emergence has facilitated access to a wide range of high-quality psychoactive substances, according to surveys of users. In this paper, we ask the question 'How does changing access to drugs through cryptomarkets affect the drug use and harm trajectories of their users?'
METHODS: We conducted a digital ethnography spanning 2012-2014, a period that included the seizure of the original Silk Road marketplace and forum by law enforcement. Using encrypted online chat, we interviewed 17 people who reported using Silk Road to purchase illicit drugs. The interviews were in-depth and unstructured, and also involved the use of life history timelines to trace trajectories. Transcripts were analysed thematically using NVivo.
RESULTS: For some, Silk Road facilitated initiation into drug use or a return to drug use after cessation. Typically, participants reported experiencing a glut of drug consumption in their first months using Silk Road, described by one participant as akin to 'kids in a candy store'. There was evidence that very high availability reduced the need for drug hoarding which helped some respondents to moderate use and feel more in control of purchases made online. Cryptomarket access also appeared to affect solitary and social drug users differently. Most participants described using other cryptomarkets after the closure of Silk Road, albeit with less confidence.
CONCLUSION: In the context of high levels of drug access, supply and diversity occurring within a community regulated environment online, the impacts of cryptomarkets upon drug use trajectories are complex, often posing new challenges for self-control, yet not always leading to harmful outcomes. A major policy challenge is how to provide support for harm reduction in these highly volatile settings.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Availability; Cryptomarkets; Digital ethnography; Drug markets; Drug trajectories; Silk Road

Mesh:

Substances:

Year:  2016        PMID: 27157539     DOI: 10.1016/j.drugpo.2016.04.006

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  6 in total

1.  Setting the baseline: a description of cannabis poisonings at a Canadian pediatric hospital prior to the legalization of recreational cannabis.

Authors:  Phoebe Cheng; Atousa Zagaran; Fahra Rajabali; Kate Turcotte; Shelina Babul
Journal:  Health Promot Chronic Dis Prev Can       Date:  2020-06       Impact factor: 3.240

2.  Listed for sale: Analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket.

Authors:  Francois R Lamy; Raminta Daniulaityte; Monica J Barratt; Usha Lokala; Amit Sheth; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2020-06-12       Impact factor: 4.492

3.  Emergence and structure of decentralised trade networks around dark web marketplaces.

Authors:  Matthieu Nadini; Alberto Bracci; Abeer ElBahrawy; Philip Gradwell; Alexander Teytelboym; Andrea Baronchelli
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

Review 4.  Potential Influences of the Darknet on Illicit Drug Diffusion.

Authors:  Angus Bancroft
Journal:  Curr Addict Rep       Date:  2022-09-10

5.  The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS.

Authors:  Elle Wadsworth; Colin Drummond; Paolo Deluca
Journal:  Brain Sci       Date:  2018-03-16

6.  Will growth in cryptomarket drug buying increase the harms of illicit drugs?

Authors:  Judith Aldridge; Alex Stevens; Monica J Barratt
Journal:  Addiction       Date:  2017-08-02       Impact factor: 6.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.